CareDx Quick Ratio 2013-2025 | CDNA

Historical quick ratio values for CareDx (CDNA) over the last 10 years.
CareDx Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2025-03-31 $0.33B $0.09B 3.84
2024-12-31 $0.33B $0.09B 3.72
2024-09-30 $0.32B $0.08B 3.87
2024-06-30 $0.30B $0.08B 3.85
2024-03-31 $0.28B $0.07B 4.03
2023-12-31 $0.29B $0.08B 3.77
2023-09-30 $0.33B $0.07B 4.50
2023-06-30 $0.34B $0.07B 4.59
2023-03-31 $0.35B $0.07B 4.92
2022-12-31 $0.37B $0.08B 4.85
2022-09-30 $0.37B $0.07B 5.27
2022-06-30 $0.39B $0.08B 4.91
2022-03-31 $0.39B $0.07B 5.88
2021-12-31 $0.42B $0.08B 5.38
2021-09-30 $0.43B $0.07B 6.11
2021-06-30 $0.43B $0.06B 7.57
2021-03-31 $0.43B $0.05B 9.29
2020-12-31 $0.26B $0.07B 3.80
2020-09-30 $0.25B $0.06B 3.99
2020-06-30 $0.24B $0.06B 4.26
2020-03-31 $0.06B $0.03B 2.09
2019-12-31 $0.07B $0.04B 1.89
2019-09-30 $0.06B $0.03B 2.01
2019-06-30 $0.06B $0.03B 2.20
2019-03-31 $0.07B $0.02B 4.42
2018-12-31 $0.08B $0.02B 3.91
2018-09-30 $0.04B $0.02B 2.36
2018-06-30 $0.03B $0.01B 1.83
2018-03-31 $0.03B $0.01B 2.06
2017-12-31 $0.02B $0.04B 0.50
2017-09-30 $0.01B $0.03B 0.35
2017-06-30 $0.01B $0.05B 0.25
2017-03-31 $0.02B $0.05B 0.32
2016-12-31 $0.02B $0.04B 0.52
2016-09-30 $0.03B $0.04B 0.70
2016-06-30 $0.02B $0.04B 0.62
2016-03-31 $0.03B $0.01B 1.90
2015-12-31 $0.03B $0.01B 3.31
2015-09-30 $0.04B $0.01B 3.55
2015-06-30 $0.04B $0.01B 4.77
2015-03-31 $0.04B $0.01B 6.62
2014-12-31 $0.04B $0.01B 3.56
2014-09-30 $0.04B $0.01B 3.73
2014-06-30 $0.01B $0.02B 0.61
2014-03-31 $0.01B $0.01B 0.83
2013-12-31 $0.01B $0.01B 1.01
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.01B $0.01B 1.09
Sector Industry Market Cap Revenue
Medical Medical Services $1.058B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $138.024B 25.89
CVS Health (CVS) United States $80.885B 10.05
Elevance Health (ELV) United States $75.961B 9.80
Cencora (COR) United States $57.110B 19.87
DiDi Global (DIDIY) China $25.792B 27.40
Labcorp Holdings (LH) United States $20.561B 16.68
Natera (NTRA) United States $20.462B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.598B 0.00
CochLear (CHEOY) Australia $12.760B 0.00
Solventum (SOLV) United States $12.748B 13.49
ICON (ICLR) Ireland $11.757B 10.93
Revvity (RVTY) United States $11.304B 19.45
Viatris (VTRS) United States $10.481B 3.60
Medpace Holdings (MEDP) United States $8.988B 23.87
Sonic Healthcare (SKHHY) Australia $8.788B 0.00
Avantor (AVTR) United States $8.736B 12.69
HealthEquity (HQY) United States $8.317B 36.43
Charles River Laboratories (CRL) United States $7.584B 14.86
Caris Life Sciences,�Inc (CAI) United States $7.355B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.851B 28.56
BrightSpring Health Services (BTSG) United States $3.527B 32.35
Sotera Health (SHC) United States $3.230B 18.35
Surgery Partners (SGRY) United States $2.799B 36.40
Alignment Healthcare (ALHC) United States $2.623B 0.00
Concentras Parent (CON) United States $2.543B 14.70
Organon (OGN) United States $2.485B 2.64
GeneDx Holdings (WGS) United States $2.331B 89.77
Progyny (PGNY) United States $1.992B 43.85
Ardent Health (ARDT) United States $1.991B 8.49
PACS (PACS) United States $1.897B 0.00
Premier (PINC) United States $1.719B 13.05
GoodRx Holdings (GDRX) United States $1.697B 33.93
Teladoc Health (TDOC) United States $1.388B 0.00
Establishment Labs Holdings (ESTA) $1.285B 0.00
Pediatrix Medical (MD) United States $1.100B 8.37
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.911B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.761B 7.13
Nutex Health (NUTX) United States $0.632B 9.57
InnovAge Holding (INNV) United States $0.564B 0.00
Embecta (EMBC) United States $0.560B 3.77
SBC Medicals (SBC) United States $0.511B 0.00
LifeMD (LFMD) United States $0.497B 0.00
Sonida Senior Living (SNDA) United States $0.473B 0.00
Auna S.A (AUNA) Luxembourg $0.472B 10.63
Omada Health (OMDA) $0.463B 0.00
So-Young (SY) China $0.455B 0.00
Enhabit (EHAB) United States $0.354B 29.17
COMPASS Pathways (CMPS) United Kingdom $0.333B 0.00
Performant Healthcare (PHLT) United States $0.309B 0.00
Oncology Institute (TOI) United States $0.265B 0.00
Beauty Health (SKIN) United States $0.207B 0.00
DocGo (DCGO) United States $0.142B 23.17
Pheton Holdings (PTHL) China $0.136B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
Ascend Wellness Holdings (AAWH) United States $0.072B 0.00
KindlyMD (NAKA) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.047B 0.00
Biodesix (BDSX) United States $0.045B 0.00
ModivCare (MODV) United States $0.045B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.035B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00